Summary by Moomoo AI
CanSino Biologics held the second shareholder meeting of the 2023 A-share employee stock ownership plan on November 25, 2024. The meeting was convened by the board of directors and chaired by Mr. Liu Ming, with 146 actual attendees holding 133,525 shares, accounting for 96.56% of the voting rights. The meeting deliberated and approved the motion to change the board of directors, electing Ms. Sui Xiuwen as a new member, while Ms. Liu Wei stepped down as a director and chairperson. On the same day, the board of directors held the third meeting and elected Mr. Liu Ming as the new chairman, with a term consistent with the duration of the stock ownership plan. Ms. Sui Xiuwen has no relevant relationship with the company's major shareholders and executives. The personnel changes were unanimously approved, with no opposing or abstaining votes.
